StockNow
Log in
Other

Novo Nordisk (NOVOB DC) says it asked court to preliminary halt Eli Lily's (LLY) misleading GLP-1 advertising campaigns while Novo Nordisk's lawsuit proceeds

StockNow breaking-news AI analysis

Novo Nordisk is suing Eli Lilly for deceptive GLP-1 advertising, claiming Lilly uses outdated clinical data to falsely imply its treatments are more effective than Novo's latest high-dosage products.

2 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Markets

Eli Lilly (LLY) Q2 2026 (USD): Adj. EPS 8.38 (exp. 6.01), Revenue 23bln (exp. 20.7bln)

LLYGeopolitics

Pakistani sources say Pakistan PM Sharif and Army Chief Munir will visit Saudi Arabia tomorrow, Al Hadath reports

U.S. Economy

US ADP Employment Change (Jul) 44K vs. Exp. 70K (Prev. 98K)